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Abstract
● AIM: To examine the association of genetic polymorphisms 
(-308)G/A TNFα, (+250)A/G Ltα, (+36)A/G TNFR1, (+1663)
A/G TNFR2 with the development of primary open angle 
glaucoma (POAG) among people in Central Russia.
● METHODS: The study sample included 443 individuals, 
of which 252 patients with POAG and 191 individuals in the 
control group. Genotyping of (-308)G/A TNFα, (+250)A/G Ltα, 
(+36)A/G TNFR1, (+1663)A/G TNFR2 was performed using 
polymerase chain reaction. The distribution of alleles 
and genotypes of the studied DNA markers in the groups 
was examined by 2×2 contingency tables and χ2 with the 
Yates’s correction for continuity and odds ratios (OR) with 
95% confidence intervals (CI).
● RESULTS: Allele (-308)G TNFα (Р=0.01, OR=1.78, 95%CI 
1.12-2.85) was identified as a risk factor for POAG. 
Homozygotes (-308) AA TNFα are at a lowest risk for 
development of the disease (Р=0.01, OR=0.0005). The 
following combination of genetic variants of cytokines 
were associated with a reduced risk of POAG: (+1663)A 
TNFR2 and (+250)G Ltα (OR=0.34)
● CONCLUSION: Genetic polymorphisms (-308)G/A TNFα, 
(+250)A/G Ltα, (+1663)A/G TNFR2 associated with the 
development of POAG in the population of Central Russia.
● KEYWORDS: primary open angle glaucoma; tumor necrosis 
factor; tumor necrosis factor receptor; gene polymorphism
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INTRODUCTION
G laucoma is a heterogeneous group of diseases characterized by progressive optic neuropathy and the typical 
reduction in visual function, being the second leading cause of 
irreversible blindness[1]. Primary open angle glaucoma (POAG) 
is the most prevalent clinical form of the disease accounting 
for 90% of all forms of glaucoma[2]. 
Currently, the etiopathogenic significance in POAG is thought 
to be due to violations in apoptosis. Tumor necrosis factors 
and their receptors are among key elements in this process[3-4]. 
Therefore, several genetic polymorphisms of tumor necrosis 
factors and their receptors have been analyzed for their 
possible association with POAG[5-11]. Among those, (-308) 
G/A TNFα (guanine to adenine substitution at position 308 of 
the TNFα promoter region) was the most commonly studied. 
The data on its association with the development of POAG 
were contradictory. For example, while in some populations 
no association of this polymorphism with the emergence of 
POAG was found[12-15], such an association was reported in 
populations from China, Iran, Egypt and Saudi Arabia[5,7,16-17].
In this study, we analyzed four polymorphisms of cytokines, 
(-308)G/A TNFα, (+250)A/G Ltα, (+36)A/G TNFR1, and 
(+1663)A/G TNFR2, for their possible association with 
development of POAG in the population of Central Russia.
SUBJECTS AND METHODS
The total study sample consisted of 443 participants, including 
252 patients with POAG and 191 individuals in the control 
group. The patients with POAG were enrolled in the study 
according to the following criteria: open anterior chamber 
angle, increased intraocular pressure (≥21 mm Hg), characteristic 
changes in the optic disc (notching, neuroretinal rim thinning, 
increased the ratio of excavation/optic disc), visual field 
defects characteristic of glaucoma (arcuate scotoma, narrowing 
of the field of view with the nose, paracentral scotoma) and 
the absence of conditions leading to secondary glaucoma. 
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The control group included individuals without POAG, acute 
diseases of the eye at the time of the survey, or any somatic 
pathology resulting in secondary injury to the eyes. All study 
participants signed a written informed consent in accordance 
with the principles of the Helsinki Declaration. The participants 
were examined at the Department of Eye Microsurgery of St. 
Iasaf Belgorod Regional Clinical Hospital. 
All  participants were genotyped for the following 
polymorphisms: (-308)G/A of TNFα (rs1800629), (+250)A/G
of Ltα (rs909253), (+36)А/G of ТNFR1 (rs767455) and 
(+1663)A/G of ТNFR2 (rs1061624). There are data about 
association of TNFα (rs1800629) and Ltα (rs909253) with 
POAG in populations from China, Iran, Egypt and Saudi 
Arabia)[5,7,16-17]. TNFR1 and TNFR2 encode the respective 
receptors. Furthermore, the selected polymorphisms may be of 
functional significance. Specifically, according to the National 
Institute of Environmental Health Sciences (NIEHS) (https://
snpinfo.niehs.nih.gov/snpinfo/snpfunc.html), rs767455 is 
located at the splicing site and has high regulatory potential 
(0.52), rs1061624 is located in the miRNA-binding site, 
both rs909253 and rs1800629 are located at the transcription 
factor binding sites (Table 1). Yet, rs1800629, rs909253, and 
rs1061624 are tag single nucleotide polymorphism (SNPs).
Genomic DNA was isolated from blood drawn from cubital 
vein of a proband. The protocol of DNA isolation was 
described elsewhere[18]. The studied loci were genotyped using 
TaqMan probes and primers described previously (Table 2). 
The allele frequencies were analyzed for their correspondence 
to the Hardy-Weinberg equilibrium (HWE) using the χ2 
criterion. The distribution of alleles and genotypes in groups 
was assessed using 2×2 contingency tables, odds ratios (OR) 
with 95% confidence intervals (CI), and the Yates’s χ2 test. A 
contribution of the genetic variants and their combinations POAG 
was analyzed, using the MCMC and Bayesian nonparametric 
statistics methods suggested by Favorov et al[23] and implemented 
in APSampler. The error of the first kind from multiple 
comparisons was corrected by a permutation test (pperm)
[24].
RESULTS
The physical characteristics of the participants are given in 
Table 3. The control group is similar to the case group by 
Table 1 SNP function prediction of the studied polymorphisms 
SNP Allele TFBS Splicing (ESE or ESS)
miRNA 
(miRanda) RP Conservation
Allele frequency
Allele European
rs1800629 A/G + - - 0.04 0 G 0.795
rs909253 G/A + - - 0.21 0 A 0.649
rs767455 C/T - + - 0.52 1 T 0.505
rs1061624 A/G - - + 0.24 0.001 A 0.541
Data is obtained using the online program from the site the National Institute of Environmental Health Sciences (https://snpinfo.niehs.
nih.gov/snpinfo/snpfunc.html). TFBS: Transcription factor binding site; ESE: Exonic splicing enhancer; ESS: Exonic splicing silencer; 
RP: Regulatory potential.
Table 2 Primers and probes used to genotype the studied polymorphisms
Polymorphisms Position in the gene 5’-3’ sequence of the primers and probes References
-308G/A TNFα (rs1800629) Promotor F: 5’-GAAATGGAGGCAATAGGTTTTGAG-3’
R: 5’-GGCCACTGACTGATTTGTGTGTAG-3’
5’-FAM-CCGTCCTCATGCC- RTQ1-3’
5’-ROX-CCGTCCCCATGCC - RTQ1-3’
Landi et al[19]
+250A/G Ltα  (rs909253) Intron 1 F: 5’-CAGTCTCATTGTCTCTGTCACACATT-3’
R: 5’-ACAGAGAGAGACAGGAAGGGAACA-3’
5’-FAM:CCATGGTTCCTCTC-RTQ1-3’ 
5’-ROX:CTGCCATGATTCC-RTQ1-3’
de Jong et al[20]
+36A/G TNFR1 (rs767455) Exon 1 F: 5’- AGCCCACTCTTCCCTTTGTC-3’
R: 5’-CCACCGTGCCTGACCTG-3’
5’- FAM: CTGCTGCCACTGGT-RTQ1 -3’
5’- ROX: CTGCTGCCGCTGGT-BHQ2 -3’
Chae et al[21]
+1663A/G TNFR2 (rs1061624) 3'UTR F: 5’- TGACCTGCAGGCCAAGAG-3’
F: 5’- CCATGGCAGCAGAGGCTTT-3’
5’-FAM: CACAACCCGCTGCC - RTQ1-3’
5’-ROX: CCACAACTCGCTGCC - BHQ2-3’
Ferguson et al[22]
Table 3 Physical characteristics of the subjects from the case and 
control groups
Characteristics Cases Controls
Total 252 191
Age, a (min-max) 70.53±8.43 (46.0-89.0)a 69.24±10.14 (40.0-87.0)
BMI 28.12±4.84a 29.04±6.01
Males 125 (49.6%)a 93 (48.7%)
Females 127 (50.4%)a 98 (51.3%)
BMI: Body mass index; aP>0.05.
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gender, age and prevalence of various comorbidities (Table 4).
Allele (-308)G TNFα was associated with an increased risk 
for POAG (Р=0.01, OR=1.78, 95% CI 1.12-2.85) (Power 
0.72), whereas homozygotes (-308)АА TNFα had a lower risk 
for development of POAG (Р=0.01, OR=0.0005, 95% CI -) 
(Power 0.79) (Table 5).
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Table 4 Comorbidities in the studied groups
Comorbidity (if any)
POAG patients Controls
χ2 (P)
n % n %
Absence of comorbidity 19 7.54 25 13.09 3.15 (0.08)
Hypertonia 162 64.29 120 62.83 0.05 (0.83)
Arterial hypotension 8 3.17 10 5.24 0.71 (0.40)
Heart atherosclerosis 55 21.83 41 21.47 0.01 (1.00)
Heart ischemia 112 44.44 78 40.84 0.44 (0.51)
Other heart pathology 11 4.37 13 6.81 0.83 (0.36)
Diabetes
Type I 2 0.79 1 0.52 0.01 (1.00)
Type II 38 15.08 27 14.14 0.02 (0.89)
Other endocrine disorders 13 5.16 7 3.66 0.27 (0.60)
Nervous system pathology 21 8.33 24 12.57 1.69 (0.19)
Kidney pathology 6 2.38 3 1.57 0.07 (0.80)
Digestive system pathology 25 9.92 13 6.81 0.98 (0.32)
Respiratory system pathology 9 3.57 3 1.57 0.98 (0.32)
Blood pathology 3 1.19 1 0.52 0.05 (0.82)
Any other pathology 32 12.70 32 16.75 1.14 (0.29)
Table 5 The frequency of genotypes and alleles of the studied polymorphisms in patients with POAG and in the control group
Polymorphisms Genotypes, alleles
Controls (n=191) POAG patients (n=252)
ОR (95% СI) χ2 (P)
n % n %
-308G/A TNFα (rs1800629) -308GG 139 76.80 208 84.21 1.61 (0.96-2.70) 3.28 (0.07)
-308GA 36 19.89 39 15.79 0.76 (0.45-1.28) 0.95 (0.33)
-308АА 6 3.31 0 0 0.0005 (-) 6.08 (0.01)
-308G 314 86.74 455 92.11 1.78 (1.12-2.85) 6.01 (0.01)
-308А 48 13.26 39 7.89 0.56 (0.35-0.90)
χ2(HWE) (P) 3.32 (>0.05) 1.81 (>0.05) -
+36A/G TNFR1 (rs767455) +36АА 44 24.58 59 23.89 0.96 (0.60-1.55) 0.01 (0.96)
+36АG 83 46.37 126 51.01 1.20 (0.80-1.80) 0.72 (0.40)
+36GG 52 29.05 62 25.10 0.82 (0.52-1.29) 0.64 (0.43)
+36А 171 47.77 244 49.39 1.07 (0.81-1.42) 0.16 (0.69)
+36G 187 52.23 250 50.61 0.94 (0.71-1.24)
χ2(HWE) (P) 0.90 (>0.05) 0.10 (>0.05) -
+1663A/G TNFR2 (rs1061624) +1663АА 36 20.57 38 15.32 0.70 (0.41-1.19) 1.61 (0.21)
+1663АG 75 42.86 128 51.61 1.42 (0.95-2.14) 2.81 (0.09)
+1663GG 64 36.57 82 33.07 0.86 (0.56-1.31) 0.41 (0.52)
+1663А 147 42.00 204 41.13 0.97 (0.72-1.29) 0.03 (0.86)
+1663G 203 58.00 292 58.87 1.04 (0.78-1.38)
χ2(HWE) (P) 2.53 (>0.05) 1.07 (>0.05) -
+250A/G Ltα (rs909253) +250АА 85 46.96 139 55.83 1.43 (0.95-2.14) 2.95 (0.09)
+250АG 81 44.75 89 35.74 0.69 (0.46-1.04) 3.19 (0.07)
+250GG 15 8.29 21 8.43 1.02 (0.49-2.15) 0.01 (1.00)
+250А 251 69.34 367 73.69 1.24 (0.91-1.69) 1.76 (0.19)
+250G 111 30.66 131 26.31 0.81 (0.59-1.10)
χ2(HWE) (P) 0.50 (>0.05) 1.52 (>0.05) -
HWE: Hardy-Weinberg equilibrium.
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The combination of the following genetic variants also showed 
association with a lower risk of POAG: (+1663)А TNFR2 
and (+250)G Ltα (Case 5.65%, Control 15.12%, Р=0.001, 
рperm=0.0003, OR=0.34, 95% CI 0.17-0.66).
DISCUSSION
The study identified the risk and protective genetic variants 
for POAG. Along with the statistically significant association 
of individual SNPs, i.e. (-308)G TNFα is a risk factor for 
POAG and (-308)AA TNFα as a protective factor, a significant 
contribution to the combination of genetic variants (+1663)
А TNFR2 and (+250)G Ltα in lowering a risk for POAG was 
found.
The role of tumor necrosis factors in POAG is of a great 
interest, because they contribute to development of optic 
neuropathy. TNFα, binding to TNFR1, either directly induces 
apoptosis of retinal ganglion cells or indirectly participates in 
the progression of glaucomatous neurodegeneration. Elevated 
intraocular pressure and vascular factors leads to the activation 
of astrocytes that produce TNFα, which in turn initiates the 
process of cell death. Moreover, activated astrocytes produce 
nitric oxide synthase (NOS-2) and thereby affect the formation 
of NO. Hyperproduction of NO and its transformation 
into peroxynitrite also induce apoptosis of retinal ganglion 
cells[3-4]. Thus, tumor necrosis factors may be involved in the 
pathogenesis of POAG as the main mediators of apoptosis, but 
the exact mechanism of the involvement of these cytokines in 
developing POAG remains unclear.
The available data about a probable role of the studied 
polymorphisms in development of POAG are inconsistent. For 
example, Chinese researchers determined higher frequency 
of allele G of the (-308)G/A TNFα polymorphism in POAG 
patients as compared to the controls (OR=1.89, 95% CI 1.14-
3.13)[6], which is in agreement with our results. On the other 
hand, several studies reported that another allele, (-308)A 
TNFα, is a risk factor for POAG[5,7,11]. Finally, some studies 
did not found any association between the (-308)G/A TNFα 
polymorphism and POAG[9-10]. 
The data about possible contribution of (+250)А/G Ltα, (+36)
A/G TNFR1 and (+1663)A/G TNFR2 to POAG are extremely 
scarce. Al-Dabbagh et al[7] reported that frequency of genotype 
+250GG Ltα was higher in the sample of 200 POAG patients 
from Saudi Arabia (P=0.001, OR=3.28), whereas genotype 
+250AG Ltα was more common in the controls (P=0.001, 
OR=0.33). These results differ from ours, which may be due to 
the different population genetic structure and/or study design. 
One study determined no association of the +36A/G TNFR1 
locus with development of POAG[5]. No studies on association 
of the (+1663)A/G TNFR2 polymorphism with POAG was 
found in the available literature.
In summary, the results of the present study suggest that allele 
(-308)G TNFα is a risk factor for POAG in a population 
of Central Russia, whereas carriers of the (-308)АА TNFα 
genotype and haplotype (+1663)А TNFR2/(+250)G Ltα 
(OR=0.34) have a lower risk to develop POAG.
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